Skip to main content
Loading

Next generation antibodies addressing the road blocks for first generations [Topic TBC]

19 Feb 2025
Lead Identification & Optimization
Industry Expert
Christopher Roth, Vice President of Research - Abilita Therapeutics, Inc.